首页|绝经后女性亚临床甲状腺功能减退患者促甲状腺素长期水平和骨代谢关系

绝经后女性亚临床甲状腺功能减退患者促甲状腺素长期水平和骨代谢关系

扫码查看
目的:了解绝经后女性亚临床甲状腺功能减退(SCH)患者的促甲状腺素(TSH)长期水平对骨代谢的影响.方法:回顾 2019-2022 年上海市虹口区江湾镇街道社区卫生服务中心内分泌全专联合门诊随访的135 例绝经后女性SCH患者临床资料,患者TSH值均在正常范围内.按TSH值低、中、高水平将患者分为A、B、C三组,随访 36 个月,比较患者的骨转换指标和骨密度.结果:随访 24 个月,三组间以及组内骨转换指标和骨密度差异均无统计学意义(P>0.05).36 个月时,A组的总Ⅰ型胶原氨基端延长肽(tP1NP)和Ⅰ型胶原羧基端肽b特殊序列(b-CTX)较另两组高(P<0.01),腰椎 1-4(L1-4)、股骨颈(NECK)、全髋(TOTEL)三处骨密度(BMD)较另两组低(P<0.01).36 个月时,A组的t P1NP、b-CTX水平高于12 个月时的基线水平(P<0.01),三处的BMD水平较 12 个月时的明显降低(P<0.05).结论:TSH正常范围内低水平对骨代谢也有影响,但存在时效关系.TSH长期稳定在中值范围(1.6 mIU/mL<TSH<2.9 mIU/mL)及以上水平有利于SCH患者骨代谢稳定,降低骨质疏松风险.
Association between long-term levels of thyroid stimulating hormone and bone metabolism in postmenopausal women with subclinical hypothyroidism
Objective:To explore the influence of the long-term levels of thyroid stimulating hormone(TSH)on bone metabolism in postmenopausal women with subclinical hypothyroidism(SCH).Methods:The clinical data of 135 postmenopausal women patients with SCH who were followed up in Endocrine General Specialty Joint Outpatient Clinic Jiangwan Community Health Service Centre of Hongkou District,Shanghai from 2019 to 2022,and the level of TSH in the patients was in the normal range.According to TSH values at low,medium,and high levels,the patients were divided into A,B,and C groups,and the bone turnover indicators and bone density of the patients were compared after 36 months follow-up.Results:There was no significant difference in bone turnover indicators and bone density among the three groups during the follow-up of 24 months(P>0.05).At 36 months,total type I collagen amino terminal extender peptide(tP1NP)and type I collagen carboxyl terminal peptide β special sequence(β-CTX)in the A group was higher than those in the other two groups(P<0.01),three bone mineral densities(BMD)of lumbar vertebrae 1-4(L1-4),neck of femur(NECK),and total hip(TOTEL)were lower than those in the other two groups(P<0.01).The levels of tP1NP and b-CTX in the A group were higher than the basic level at 12 months(P<0.01),the levels of three BMD was significantly lower than that at the 12 months(P<0.01).Conclusion:Low levels of TSH within the normal range have an impact on bone metabolism,but there is a time effect relationship.Long term stability of TSH within the median range(1.6 mIU/mL<TSH<2.9 mIU/mL)or above is beneficial for bone metabolism stability in patients with SCH and reduces the risk of osteoporosis.

subclinical hypothyroidismpostmenopausalthyroid stimulating hormonebone metabolismbone mineral density

方圆

展开 >

上海市虹口区江湾镇街道社区卫生服务中心全科,上海 200434

亚临床甲状腺功能减退 绝经后 促甲状腺素 骨代谢 骨密度

2024

上海医药
上海医药行业协会

上海医药

影响因子:0.781
ISSN:1006-1533
年,卷(期):2024.45(14)